Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hera-MI logo — Shaping the future of radiology by making AI & Radiologists...

Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection

Founded 2017 France France 22 employees Non Equity Assistance AI, Biotechnology +1

General Information

Company Name Hera-MI
Founded Year 2017
Location France France
Employees 22
Industries AI, Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Hera-MI. To contact Hera-MI, visit hera-mi.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hera-MI compare?

A PDF of Hera-MI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hera-MI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hera-MI

Hera-MI is a startup based in France founded in 2017 with a mission to shape the future of radiology by utilizing AI and radiologists to enhance early detection of breast cancer. The company is focused on leveraging AI to increase the recovery rate and optimize healthcare treatment for women. Hera-MI is addressing the significant issue of breast cancer, which is one of the leading causes of cancer among women. The early detection of breast cancer is crucial, as almost 90% of patients can recover when diagnosed early. Hera-MI is developing a clinical decision support system that is based on machine learning and medical imaging processing. This system aims to improve the early detection of breast cancer while enhancing the quality and accuracy of diagnosis. Additionally, it reduces the interpretation time for radiologists, thereby improving overall efficiency. The startup's solution not only focuses on technological advancement but also emphasizes patient care improvement. By providing more efficient breast cancer screening, Hera-MI enables women to receive earlier treatment, thereby increasing their chances of recovery. Recently, Hera-MI received non-equity assistance from MassChallenge in an investment round that took place on 21 October 2020. The investment signifies the confidence of the industry in the potential of Hera-MI's innovative approach to revolutionizing breast cancer detection and treatment. With its focus on AI, biotechnology, and healthcare, Hera-MI is poised to make a significant impact on the future of radiology and women's healthcare.

Business keywords: Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, CAD, Digital Medical Imaging, Early-stage Diagnosis, Healthcare Innovation

Services & Products

Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis

Target Customers

Radiologists senologists healthcare institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Hera Undisclosed 1
MassChallenge
MassChallenge
21 Oct 2020

Hera-MI Alternatives & Competitors

View All Alternatives
Hera-MI vs
MICA AI Medical
MICA AI Medical Israel

Mammography Image Comparison Analysis - Improving Early Detection Of Breast Cancer

Seed
9 employees
AI, Health Care
Compare Hera-MI vs MICA AI Medical
Hera-MI vs
Delphinus Medical Technologies, Inc.
Delphinus Medical Technologies, Inc. United States

Delivering medical innovations to transform early detection of breast cancer and save women’s lives...

Growth
34 employees
Biotechnology, Health Care
Hera-MI vs
b-rayZ
b-rayZ Switzerland

Empower Mammography through Artificial Intelligence

Series A
20 employees
AI, Analytics
Also compare with: Hera-MI vs Lunit Cancer Screening Lunit Cancer Screening View all alternatives

FAQ About Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection
Hera-MI was founded in 2017.
Hera-MI is headquartered in France.
Hera-MI operates in AI, Biotechnology and Health Care. Its work centres on Breast Cancer, Mammography, Tomosynthesis and MRI. Its customers include Radiologists, senologists and healthcare institutions.
Hera-MI has approximately 22 employees.
Hera-MI has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Hera-MI offers: Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis.
Top alternatives and competitors to Hera-MI include MICA AI Medical, Delphinus Medical Technologies, Inc., b-rayZ, Lunit Cancer Screening, AIGEA Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hera-MI and MICA AI Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hera-MI, https://bouncewatch.com/company/hera-mi, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes